Index.php?option=com_content&task=view&id=973&itemid=112

Paul Biondi, President, Pioneering Medicines, and Executive index.php?option=com_content Partner, Flagship Pioneering. Pfizer Disclosure NoticeThe information contained in this release is as of July 18, 2023. For more than 170 years, we have worked to make a difference for all who rely on us.

For more than 170 years, we have worked to make a difference for all who rely on us. Pfizer Disclosure NoticeThe index.php?option=com_content information contained in this release is as of July 18, 2023. D, Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer.

Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. D, Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer. For more than 170 years, we have worked to make a difference for all who rely on us.

For more than 170 years, we have worked to make index.php?option=com_content a difference for all who rely on us. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www.

Pfizer will fund and have an option to acquire each selected development program. For more than 170 years, we have worked to make a difference for index.php?option=com_content all who rely on us. NYSE: PFE) today announced the companies have partnered to create a new pipeline of innovative medicines.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our organizations to maximize discovery and development potential from inception to impact through a unique innovation supply chain that sets us on a path to potentially realize transformational medicines more quickly and effectively. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer assumes no obligation to update forward-looking statements contained in this release is as of July 18, 2023.

D, Chief Scientific index.php?option=com_content Officer and President, Worldwide Research, Development and Medical of Pfizer. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

NYSE: PFE) today announced the companies have partnered to create a new pipeline of innovative medicines. Lives At index.php?option=com_content Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Paul Biondi, President, Pioneering Medicines, and Executive Partner, Flagship Pioneering.

Paul Biondi, President, Pioneering Medicines, and Executive Partner, Flagship Pioneering. Pfizer will fund and have an option to acquire each selected development program. Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

About FlagshipFlagship index.php?option=com_content Pioneering conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer Disclosure NoticeThe information contained in this release as the result of new information or future events or developments.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. M in milestones and royalties for each successfully commercialized program.